EGFR tyrosine kinase inhibitors in the treatment of advanced non-small cell lung cancer

被引：0
|
作者：
Kowalski, D. M. [1 ]
Krzakowski, M. [1 ]
Jaskiewicz, P. [1 ]
Janowicz-Zebrowska, A. [1 ]
Glogowski, M. [1 ]
机构：
[1] M Sklodowska Curie Mem Canc Ctr & Inst, Warsaw, Poland
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2008年 / 26卷 / 15期
关键词：
D O I：
10.1200/jco.2008.26.15_suppl.19117
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
19117
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The role of EGFR tyrosine kinase inhibitors in the treatment of non-small cell lung cancer
    Kowalczyk, Anna
    Szutowicz-Zielinska, Ewa
    Dziadziuszko, Rafal
    Jassem, Jacek
    [J]. ONCOLOGY IN CLINICAL PRACTICE, 2005, 1 (04): : 217 - 224
  • [2] Drug Resistance to EGFR Tyrosine Kinase Inhibitors for Non-small Cell Lung Cancer
    Shien, Kazuhiko
    Yamamoto, Hiromasa
    Soh, Junichi
    Miyoshi, Shinichiro
    Toyooka, Shinichi
    [J]. ACTA MEDICA OKAYAMA, 2014, 68 (04) : 191 - 200
  • [3] Treatment outcomes with tyrosine kinase inhibitors in patients with uncommon EGFR mutations in non-small cell lung cancer
    Hunter, S.
    Nickless, G.
    Ghosh, S.
    Lal, R.
    Merrick, S. A.
    Montes, A.
    Smith, D.
    Spicer, J.
    Karapanagiotou, E.
    [J]. LUNG CANCER, 2017, 103 : S34 - S35
  • [4] Targeting non-small cell lung cancer with small-molecule EGFR tyrosine kinase inhibitors
    Singh, Mahaveer
    Jadhav, Hemant R.
    [J]. DRUG DISCOVERY TODAY, 2018, 23 (03) : 745 - 753
  • [5] EGFR tyrosine kinase inhibitors in non-small cell lung cancer: treatment paradigm, current evidence, and challenges
    Tfayli, Arafat
    Mohty, Razan
    [J]. TUMORI JOURNAL, 2021, 107 (05): : 376 - 384
  • [6] Mechanisms of resistance to reversible inhibitors of EGFR tyrosine kinase in non-small cell lung cancer
    Krawczyk, Pawel
    Mlak, Radoslaw
    Powrozek, Tomasz
    Nicos, Marcin
    Kowalski, Dariusz M.
    Wojas-Krawczyk, Kamila
    Milanowski, Janusz
    [J]. WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY, 2012, 16 (05): : 401 - 406
  • [7] EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
    Xiuning Le
    Eric Nadler
    Daniel B. Costa
    John Victor Heymach
    [J]. Targeted Oncology, 2023, 18 : 807 - 817
  • [8] EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast
    Le, Xiuning
    Nadler, Eric
    Costa, Daniel B.
    Heymach, John Victor
    [J]. TARGETED ONCOLOGY, 2023, 18 (06) : 807 - 817
  • [9] EGFR tyrosine kinase inhibitor in advanced non-small cell lung cancer with wild-type EGFR
    Wang, Z.
    Wu, Y. L.
    Yang, J.
    Wang, B.
    Huang, Y.
    Zhou, Q.
    Xu, C.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [10] Emerging MET tyrosine kinase inhibitors for the treatment of non-small cell lung cancer
    Fujino, Toshio
    Suda, Kenichi
    Mitsudomi, Tetsuya
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2020, 25 (03) : 229 - 249
12345